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ANALYSIS OF NON-IGNORABLE MISSING AND LEFT-CENSORED
LONGITUDINAL BIOMARKER DATA
Abdus Sattar, PhD
University of Pittsburgh, 2009
In a longitudinal study of biomarker data collected during a hospital stay, observations
may be missing due to administrative reasons, the death of the subject or the subject’s
discharge from the hospital, resulting in non-ignorable missing data. Standard likelihood-
based methods for the analysis of longitudinal data, e.g, mixed models, do not include a
mechanism that accounts for the different reasons for missingness. Rather than specifying
a full likelihood function for the observed and missing data, we have proposed a weighted
pseudo likelihood (WPL) method. Using this method a model can be built based on available
data by accounting for the unobserved data via weights which are then treated as nuisance
parameters in the model. The WPL method accounts for the nuisance parameters in the
computation of the variances of parameter estimates. The performance of the proposed
method has been compared with a number of widely used methods. The WPL method is
illustrated using an example from the Genetic and Inflammatory Marker of Sepsis (GenIMS)
study. A simulation study has been conducted to study the properties of the proposed
method and the results are competitive with the widely used methods.
In the second part, our goal is to address the problem of analyzing left-censored lon-
gitudinally measured biomarker data when subjects are lost due to the above mentioned
reasons. We propose to analyze one such biomarker, IL-6, obtained from the GenIMS study,
using a weighted random effects Tobit (WRT) model. We have compared the results of the
WRT model with the random effects Tobit model. The simulation study shows that the
WRT model estimates are approximately unbiased. The correct standard error has been
iv
computed using asymptotic pseudo likelihood theory. The use of multiple weights across the
panel improves the estimate and produces smaller root mean square error. Therefore, the
WRT model with multiple weights across panels is the recommended model for analyzing
non-ignorable missing and left-censored biomarker longitudinal data.
Model selection is an extremely important part of the analysis of any data set. As
illustrated in these analyses, conclusions, which can directly impact public health, depend
heavily on the data analytic approach.
v
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1.0 INTRODUCTION
The primary goal of a longitudinal study is to characterize the change in the response variable
during the study period and to measure the effects of factors on the response variable. But
many longitudinal studies suffer from the problem of missing data. The presence of missing
data has many implications in longitudinal data analysis including unbalanced design, loss
of information, bias and hence misleading inferences about the change in the mean response
(Fitzmaurice et al., 2004). To obtain a valid inference, the reasons for any missing data,
known as the missing data mechanism, must be considered with proper care. The missing
data mechanism is said to be missing completely at random (MCAR) if the probability of
missing a response is unrelated to either the unobserved or the observed responses. If the
probability of missing a response depends on the observed response values but does not
depend on the unobserved response values then it is called missing at random (MAR). The
missing data mechanisms, MCAR and MAR, are also known as ignorable because it is not
necessary to model the missing data process as a part of the likelihood based analysis. The
missing data mechanism is said to be missing not at random (MNAR) if the probability of
missing is associated with the unobserved response values that should have been obtained.
This process is often referred to as non-ignorable missingness due to the fact that the missing
data mechanism must be considered to make a valid inference about the distribution of the
responses (Little and Rubin, 2002, Fitzmaurice et al, 2004, Allison, 2002). In a longitudinal
study the term dropout refers to the situation where a response at a particular time being
missing, implies that all the subsequent follow-up responses are also missing (Fitzmaurice
et al, 2004, Little and Rubin, 2002). In the Genetic and Inflammatory Markers of Sepsis
(GenIMS) study (Kellum, et al. 2007), biomarkers were measured daily on many of the
hospitalized subjects for a period of one week or longer. In the GenIMS study (details in
1
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Figure 1.1: Median Antithrombin levels for a period of seven days by the follow-up category.
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Chapter 3), the data are missing due to death, discharge from the hospital and administrative
reasons. Figure 1.1 presents the median levels and trend of a biomarker, anti-thrombin, over
the first seven days. Anti-thrombin is a small serum protein that interfere with coagulation
cascade in the blood and the deficiency of this protein is associated with increasing risk of
developing blood clot. The subjects who have dropped-out (669 subjects) during the study
period had a higher level of anti-thrombin, followed by completers (330) and deaths (19).
This figure illustrates that dropout and death led to substantial loss of information.
There are a number of approaches for analyzing longitudinal data with different types
of missingness. If the missingness is MCAR then analyzing only the complete subject’s
information is known as a complete-case analysis. Due to the removal of subjects from the
study, the reduced sample size often leads to inefficient estimates and reduced statistical
power. A similar approach for handling missing longitudinal data is the analysis of available
data. Though this approach covers more data when compared to the complete case analysis,
statistical methods used for analyzing available data will produce biased estimates unless the
the missingness is MCAR. A traditional method for handling missing data is the imputation
method in which the missing data are replaced by the imputed data and standard statistical
methods are then used for analyzing the full data set. The issue with the imputation method
is how to obtain a valid data set for the missing data. An alternative approach for handling
missing longitudinal data is to weight observed data (Robins et al., 1995, Fitzmaurice, et
al., 2004, Demirtas, 2004, Dufouil et al., 2004). The attraction of these methods is that once
the data set has been constructed, standard methods for analyzing longitudinal data such
as weighted generalized estimating equations (WGEE) and mixed models can be applied.
In longitudinal studies, the missingness can be due to any of the following reasons: death
of a subject, withdrawal from the study, or loss to follow-up. These differential reasons for
missingness in longitudinal data analyses present a challenge to the statistical analyst. The
losses of data can result in biased estimates and a loss in precision. The loss in precision is
proportional to the amount of missing data. In addition, the effect depends on the association
between the observed data and the missing data. Improper adjustment or no adjustment
for missing data in a regression analysis can result in biased estimates of parameters and
lead to erroneous inferences (Hogan et al., 2004). There are some likelihood based methods
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such as selection models, mixture models and shared parameter models that can be used for
analyzing non-ignorable missing longitudinal data (details in Chapter 2). In these modeling
approaches identification of parameters is problematic and implementation of these methods
is not trivial. In addition, none of the likelihood based approaches adjust the likelihood
function for differential reasons for missingness. To account for the differential reasons for
missingness, we will compute the probabilities of observing a response for a subject belonging
to a missingness category and invert this probability to obtain the weights. This basic idea
of weighting adjustments to reduce the bias in estimation is common in sample survey for
finite population randomization inference (Horvitz and Thompson, 1952). These derived
weights will be used in weighted pseudo-likelihood (WPL) methods for analyzing differential
reasons for missing longitudinal biomarker data (Lawless et al., 1999). The proposed WPL
methods will be relatively easy to implement using standard statistical software, and provide
an extension to the currently available methods for analyzing differential missingness.
In a longitudinal study of a biomarker with differential reasons for missingness, some
measurements of the biomarker may also be censored. In the GenIMS study there are
measurements that are left-censored for a panel of biomarkers. The left-censored data are
characteristic of many bioassays due to the inherent limit of quantification in the assays. In
the GenIMS study the censoring of the biomarker measurements occurred when the level
of the biomarker was below the detection limit of the assay. Moreover, there are missing
measurements that occurred primarily when the subjects in the study were discharged from
the hospital or died. In addition to differential reasons for dropout and death, left-censoring
leads to another level of complication in analyzing longitudinally measured biomarker data.
There are few methods for analyzing left-censored longitudinal data. Tobit regression
is one of the classical approaches for analyzing left-censored data (Tobin, 1958, Amemiya,
1984). A semi-parametric estimator was derived using a fixed effect tobit model for panel
data (Honore, 1992). A tobit-based variance components method has been developed to
account for the censoring process in a variance component analysis (Epstein et al., 2003).
Standard linear mixed models are used by omitting the censored data or imputing a fixed
value. The most widely used methods for left-censored longitudinal data are imputing the
quantification limit (Keet et al.,1997), using half of this limit (O’Brien et al.,1998) or the
4
use of random imputation procedures (Paxton et al.,1997). Omitting censored data clearly
results in a loss of information and the statistical properties of imputing a value are unclear
(Beal, 2001). All of these ad-hoc methods for left-censored longitudinal data produce biased
estimates and incorrect standard errors (Ghebregiorgis, 2008). A more efficient approach to
multiple imputation has been proposed for analyzing censored longitudinal data using a linear
mixed model (Hugues, 1999, Jacqmin-Gadda et al.,2000). In the case of left-censored and
informative dropout longitudinal data, a maximum likelihood method has been developed
to estimate parameters and standard errors (SE) were computed from a numerically derived
observed information matrix (Lyles et al., 2000). All of these approaches are based on the full
likelihood method. Using the full likelihood, the estimation of parameters and computation
of the SE involve a series of multiple integration, numeric and algebraic complexities. When
the rate of censoring is high, the integration becomes prohibitive and estimates are unstable
for more than two random effects (Ghebregiorgis, 2008).
In summary, this research focus on addressing two statistical issues for analyzing longi-
tudinally measured biomarker data.
First. The first issue is the non-ignorable missingness due to the differential reasons
for dropout, and death. We are proposing to extend the pseudo likelihood method to the
weighted pseudo likelihood (WPL) method for analyzing longitudinally measured biomarker
data. In this new method weights will be used for the adjustment of the missing data and
considered as nuisance parameters in the analysis. The consistent estimate of the variance
covariance matrix of the parameters of interest will be computed by considering the fact that
there are an infinite number of nuisance parameters used in the estimation process.
Second. The second issue is the left-censoring along with the non-ignorable missingness
in analyzing longitudinal biomarker data. We are proposing to extend the theory of Tobit
regression for the left-censored data to develop a Weighted Random Effects Tobit regression
model using WPL theory for non-ignorable missing and left-censored longitudinal biomarker
data. Again, the effect of infinitely many nuisance parameters (weights) in the estimation
process will be taken into account and various censoring process will be compared to find a
best one for analyzing left-censored and non-ignorable missing data. Correct standard errors
of estimates will be computed using WPL theory.
5
The performance of the fitted models will be compared with a number of widely used
models. So far to our knowledge no one has utilized the WPL theory in analyzing non-
ignorable missing and/or left-censored longitudinal data.
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2.0 A REVIEW OF LIKELIHOOD METHODS FOR ANALYZING
NON-IGNORABLE MISSING AND LEFT-CENSORED LONGITUDINAL
BIOMARKER DATA
2.1 LIKELIHOOD BASED METHODS FOR ANALYZING
NON-IGNORABLE MISSING LONGITUDINAL DATA
The classical repeated measures design has been used for analyzing longitudinally measured
continuous data. In this design, each subject is measured a fixed number of times under
different conditions to compare the effect of (usually) treatments. In a repeated measures
design the experimental conditions are the within-subject factors which are usually compared
using within-subject contrasts. In this design, each subject acts as his or her own control
and the estimate of the effects of the factor are free of any between subject variation in the
outcome (Fitzmaurice, et al. 2004). This design is not suitable for the case where there
are an unequal number of repeated measures and also has very strict assumptions on the
variance covariance structure of the measures. Moreover, there is no method that allows for
missing data using this design.
The linear mixed model is widely used for modeling longitudinally measured continuous
data. It is a generalization of the standard linear model and allows for flexibility. There are
many choices that can be made for the variance covariance structure of the correlated data
in this modeling. In this model the number of repeated measures can vary from individual
to individual and missing data can be handled under the assumption of missing at random
(MAR). If the data are missing not at random then one can not use the linear mixed model
directly. When the probabilities of response depend on the unobserved level of biomarker
data, then the missingness mechanism is known as not missing at random (NMAR) (Little
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and Rubin, 2002). In such a scenario, the standard likelihood based methods for analyzing
longitudinal biomarker data do not include a mechanism for incorporating different reasons
for loss to follow-up or death. When biomarker measurements are missing due to dropout or
death, the two types of loss to follow-up are different and should not be combined (Dufouil
et al., 2004, p.2215).
The majority of MNAR longitudinal data analysis techniques are based on a factorization
of the joint distribution f(Y,R|X), where Y is the full response data, X is the covariate
and R indicates the missing data mechanism (Hogan et al. 2004, p. 1466). Likelihood
based approaches such as the selection model, mixture model and shared parameter model
are common for modeling non-ignorable missing longitudinal data. If the regression model
is based on the joint distribution which is a product of the full data model, f(y|x) and
f(r|y, x) then it is called a selection model. In selection modeling, the identification of
model parameters depends on some unverifiable model assumptions. Generally this modeling
technique requires specialized numerical routines for maximizing the likelihood function with
the uncertainty of a well behaved likelihood function and consequently unstable estimation
of the model parameters (Kenward, 1998). If the full data is modeled as a mixture over
drop-out categories then it is a (pattern) mixture model (f(y, r|x) = f(y|r, x)f(r|x)). These
models are under-identified and well suited for small percentages of missing observations
(Little, R.J.A., 1994, Little, R.J.A., 1993, Little, R.J.A. and Wang, Y., 1996, Daniels, M.J.
and Hogan, J.W. 2000). In modeling, if a latent random effect is being used to characterize
the dependence between the response, Y, and the missing data indicator, R, then it is known
as shared latent process model. With these models, the identification is heavily dependent
on the distribution of the arbitrarily chosen shared random effects which affects the validity
of the findings (Pulkstenis, et al., 1998).
In the full data modeling setting every observation is equally weighted. For modeling
data with missing observations, weighting techniques have been used for semi-parametric
regression modeling (Robins et al., 1994, 1995). The weighting procedure has been applied
in analyzing many incomplete longitudinal data problems by Rotnitzky and Robins (1997),
Lipsitz et al (1999), Lin (2003), Demirtas (2004), Dufouil et al (2004), Lin et al (2004),
Ibrahim et al (2005). Weights are computed by inverting the probabilities of response. In a
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longitudinal study some subjects are more likely to complete the study than others. There-
fore, our intention is to apply the weighting methodology in the setting of likelihood-based
approaches. The pseudo-likelihood approach has been used for estimating parameters in
generalized linear mixed models (Wolfinger and O’connell, 1993). Therefore, our goal is to
estimate the parameters of a regression model for longitudinal data with differential rea-
sons for loss to follow-up by extending the existing full likelihood approaches such as the
mixed model and pseudo-likelihood methods. In this endeavor, we propose a model for
longitudinal biomarker data with non-ignorable non-monotone missingness using a weighted
pseudo-likelihood method. To our knowledge, these proposed estimation methods for ana-
lyzing longitudinal biomarker data with differential reasons for missingness do not appear in
the literature.
For the pseudo-likelihood methods the weights are treated as the nuisance parameters.
Nuisance parameters are the parameters which are not of direct inferential interest in the
modeling. Our interest is to estimate the usual regression coefficients (parameters) of a
general linear mixed effects model. A general method to eliminate the nuisance parameter is
via the profile likelihood method but the estimates are biased when the number of nuisance
parameters becomes large and the bias does not go away even for large samples, particularly
when there are infinitely many nuisance parameters (Pawitan (2001), p. 274). Rather than
being based on the observed data likelihood function, an estimate of the parameter of interest
can be obtained if we use the observed response only and weight (nuisance parameters) their
contribution to the likelihood function by inverting the probability of response (Lawless et
al. 1999, p. 421). This approach will be called the weighted pseudo maximum likelihood
method of estimation which basically uses the idea of the Horvitz-Thompson estimation
procedure applied in unequal probability sampling (Thompson (2002), p.53).
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2.2 LIKELIHOOD BASED METHODS FOR ANALYZING
NON-IGNORABLE MISSING AND LEFT-CENSORED
LONGITUDINAL DATA
In addition to non-ignorable missingness, analysis of censored longitudinal biomarker data
is a challenge. A standard method for the analysis of censored data is Tobit regression (To-
bin, 1958). Tobit regression has been extended to multivariate regression (Amemiya, 1984).
Recently a Box-Cox transformation has been used for the analysis of left-censored cross sec-
tional data (Han and Kronmal, 2004). In fitting linear mixed effect models, the Markov
Chain Monte Carlo (MCMC) EM algorithm has been used to accommodate censoring in
longitudinal data (Hughes, 1999). Lyles et al (2000) analyzed left-censored and informative
dropout HIV data by maximizing a single likelihood function which has integrated the cen-
soring and informative dropout process. They estimate the parameters from this complicated
likelihood function and compute the standard errors using the observed information matrix
directly. Linkage analysis of left-censored trait data has been based on a variance compo-
nent tobit model (Epstein, et al. 2003). In this modeling approach, the standard generalized
liner mixed model has been modified using the idea of Tobit model to accommodate the
censored data. As used in these references, there are many issues in analyzing left-censored
longitudinal data using a full likelihood. Beyond the algebraic and numeric intractability, it
requires computation of a series of multiple integrals and becomes intractable for the case of
a high rate of censoring. In addition, for more than two random effects the convergence of
the estimates remains uncertain (Ghebregiorgis, 2008). As a remedy, the pseudo likelihood
method has been used for analyzing multivariate longitudinal biomarker with left-censored
data (Ghebregiorgis, 2008). But this method has not been developed for left-censored single
longitudinal biomarker data with non-ignorable missingness.
The above mentioned standard and practiced methods for left-censored longitudinal data
have no mechanism for incorporating differential reasons for loss to follow up, which can
present problems. In this study we are proposing a weighted pseudo likelihood method for
left-censored and non-ignorable missing longitudinal data. This method will be compared
with the un-weighted random effect tobit model, and with the weighted random effect tobit
10
model. The weights will be computed by inverting the probability of measuring a biomarker
measurement from a subject using a multinomial logistic regression model. To the best of our
knowledge, no one has addressed the problem of analyzing left-censored and non-ignorable
missing longitudinal biomarker data using a weighting technique. In addition to the real
data analysis, an extensive simulation will be performed to understand the variability in
the inferences under different scenarios (or designs), percentages of missing and censoring
processes.
11
3.0 ANALYSIS OF LONGITUDINAL BIOMARKER DATA WITH
DROPOUT AND DEATH USING WEIGHTED PSEUDO LIKELIHOOD
THEORY
3.1 INTRODUCTION
In longitudinal studies the data are collected over a period of time from each individual in
the study resulting in missing data for a variety of reasons. A popular method for analyzing
longitudinal data is linear mixed model which assumes that the missing data mechanism
is missing at random (MAR). When the missing data mechanism is missing not at ran-
dom (MNAR), then the standard linear mixed model cannot be used in analyzing these
types of data. Though there are a few composite likelihood-based methods for analyzing
non-ignorable missing longitudinal data, there is a lack of statistical methods for analyz-
ing longitudinal data when the data are missing due to premature dropouts, deaths of the
subjects, and administrative reasons, etc. In this work we are proposing a weighted pseudo
likelihood (Lawless, et al. 1999) method for analyzing differential reasons for missing longi-
tudinal continuous biomarker data in the linear mixed model frame work.
The motivation for this study comes from the Genetic and Inflammatory marker of sep-
sis study (GenIMS). The GenIMS study was a longitudinal cohort study of subjects with
community acquired pneumonia that were recruited from 2001-2003 in 28 hospitals located
in Pennsylvania, Connecticut, Michigan and Tennesse. One major goal of the GenIMS study
was to understand the role of inflammatory markers in the progression of pneumonia to sep-
sis (Kellum, et al, 2007). In this study, one of the important biomarkers for understanding
the mechanisms of progression to sepsis is anti-thrombin. Longitudinal anti-thrombin mea-
surements were obtained for the first seven days in the study, but some of the measurements
12
are missing due to subject discharge from the hospital or death within the first seven days.
In addition, there was intermittent missingness in the measurements due to administrative
and other reasons. Figure 1.1 presents the median level and the trends of the anti-thrombin
biomarker data for the three groups of subjects over the seven day period. The subjects
who have dropped out from the study (579 subjects) had the highest level of anti-thrombin,
followed by the subjects who have completed the study (341 subjects) due to a full seven
days of hospitalization with no missing data, and the subjects who died during the first seven
days of hospitalization (19 subjects). This mechanism of missingness leads to non-ignorable
missingness which can impact estimation and any inferences drawn from the data (Little and
Rubin, 2002). This plot points to the differences in the anti-thrombin levels in these three
groups of subjects and the need to account for these differences in the analysis as illustrated
by the fact that subjects who died had the lowest anti-thrombin levels during the study.
Many longitudinal methods do not routinely incorporate missing data patterns into the
analysis. The problem is further complicated in settings such as those presented here, where
missing values occur due to reasons that may impact the outcome variable of interest. When
measurements of biomarkers are missing due to dropout or death, the two types of loss to
follow-up are different and should not be combined since the outcome may differ due to
the reason for missingness (Dufouil et al., 2004). Likelihood based approaches such as the
selection model, mixture model, and shared random effects model are common techniques
for modeling non-ignorable missing longitudinal data (Rubin, 1977; Wu and Bailey, 1988;
Little, 1994; Fallmann and Wu, 1995; Kenward, 1998; Hogan et al. 2004). Recently, joint
modeling has also been proposed as another likelihood based method for the modeling of
non-ignorable longitudinal missing data (Tsiatis and Davidian, 2004). A Pseudo-likelihood
approach has also been used for the estimation of parameters in generalized linear mixed
models (Wolfinger and O’connell, 1993).
In modeling settings where there are no missing data, each observation is equally weighted.
For modeling data with missing observations, inverse probability weighting (IPW) techniques
(Horvitz and Thomson, 1952) have been applied to semi-parametric regression modeling to
give different weights to account for the probability of missingness (Robins et al., 1994,
1995). In the current literature, this weighting procedure has been applied for analyzing
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many incomplete longitudinal data problems (Rotnitzky and Robins, 1997; Lipsitz et al,
1999; Lin, 2003; Demirtas, 2004; Lin et al, 2004; Ibrahim et al, 2005). Our objective here
is to estimate the parameters of a linear mixed model for longitudinal data with differential
reasons for loss to follow-up by utilizing the weighted pseudo-likelihood (WPL) theory. We
will estimate weights for each observation by inverting the probabilities of response. These
estimated probabilities are proportional to the likelihood of measuring the values of the
biomarker and computed using the logistic regression. Since most statistical packages con-
tain options for accommodating weights, the estimated IPW can easily be placed into the
log-likelihood function and hence the estimated quantities and inference will account for the
non-ignorable missingness in the data. These weights will be used as an adjustment of the
loss to dropout or death data. The price for incorporating these estimated weights into the
likelihood function is that the number of nuisance parameters becomes large. The number
of nuisance parameters is proportional to the number of occasions of measurement and the
number of subjects in the study. So there is a need for statistical methods for estimating
the parameters of interests in the presence of a large number of nuisance parameters in like-
lihood based inferences that include differential reasons for missing longitudinal data. In
this endeavor our proposed WPL approach, which is an extension of the pseudo-likelihood
approach (Lawless et al., 1999), will eases the numerical complexities. The wide use of longi-
tudinal data modeling in many fields of application with the challenge of differential reasons
for missingness is improved with these weighted estimation methods in the framework of
standard statistical software.
Under the different underlying assumptions about the populations and pattern of missing-
ness, we will compare the performance of the standard linear mixed model and the weighted
linear mixed model with the proposed weighted linear mixed model fitted by the WPL the-
ory. The methods are compared in terms of the bias, efficiency, root mean square error, and
coverage probability. In the next section, we will describe likelihood based methods as well
as our proposed methods for analyzing non-ignorable missing longitudinal biomarker data.
In section 3.3 we will present the results from the analysis of GenIMS study data and in
section 3.4 we will describe a simulation study to judge the performance of all estimators.
In the section 3.5 will provide a discussion.
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3.2 NOTATIONS AND MODEL FRAME WORK
Let Yij denote the measurement of a biomarker from the ith subject at the jth wave of
measurements at time tij, i = 1, 2, ..., N, j = 1, 2, ..., ni and Xij = (Xij1, Xij2, ..., Xijp)
′ denote
a p× 1 vector of covariates associated with Yij. In vector notation, Yi = (Yi1, Yi2, ..., Yini)′ is
the ni-dimensional vector of biomarker measurements andXi is the ni×pmatrix of covariates
from the ith subject. However, in most longitudinal study the vector, Yi is not always fully
observed. Suppose that the observed and missing component of Yi are denoted by Y
o
i and
Ymi respectively. We define the missingness indicator vector Ri = (Ri1, Ri2, ..., Rini)
′ where
Rij =0 if Yij is observed, =1 otherwise. Note, in this paper we will assume that Yi and Yi′ ,
(i 6= i′), are independent and the covariates vector Xij is fully observed.
Little and Rubin (2002, p. 118) defined the joint density of the full data (Yi,Ri) as,
f(yi, ri|Xi, Zi,γ,ψ) (3.1)
where Xi and Zi are design matrices for fixed and random effects respectively, and (γ, ψ)
is the parameter space for this joint density. Let β and α denote the parameter vectors
associated with Xi and Zi respectively, then γ=(β,α) and ψ characterizes the observed
response and missingness process respectively. Replacing Yi by (Y
o
i ,Y
m
i ) the full data
density can be written as,
f(yoi ,y
m
i , ri|Xi, Zi,γ,ψ) (3.2)
Using the full data density (2), the full likelihood function of the parameter space (γ,
ψ) can be written as
L∗(γ,ψ) =
N∏
i=1
f(yoi ,y
m
i , ri|Xi, Zi,γ,ψ) (3.3)
Since parameter estimation and inference are based on the observed data, so the full
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likelihood function (3) is proportional to following observed data likelihood:
L(γ,ψ) =
N∏
i=1
f(yoi , ri|Xi, Zi,γ,ψ)
=
N∏
i=1
∫
f(yi, ri|Xi, Zi,γ,ψ)dymi
=
N∏
i=1
∫
f(yoi ,y
m
i |Xi, Zi,γ)f(ri|yoi ,ymi , Xi,ψ)dymi
(3.4)
where the limits of integration are over the values of unobserved biomarker, Ymi .
If the distribution of observed response and probability of missingness can be specified
correctly, then the maximum likelihood estimates can be obtained using likelihood equation
(4) and the asymptotic covariance matrix of the estimates can be obtained by inverting the
observed Fisher information matrix (Little and Rubin (2002), p. 315). The full specification
of the likelihood function (4) involves the identification of the distribution of f(yi|Xi, Zi,γ)
and multinomial distribution of the probability of missingness, f(ri|yi, Xi, Zi,ψ). Estimation
of the parameter of interest, γ, involves the estimation of many nuisance parameters ψ. The
number of nuisance parameters increases as to the number of subjects and measurement time
increases. A general method to eliminate the nuisance parameter is via the profile likelihood
method but the estimates are biased when the number of nuisance parameters become large
and the bias persists for large samples, particularly when there are infinitely many nuisance
parameters (Pawitan (2001), p. 274). Rather than basing the estimation on the observed
data likelihood function (4), an estimate of γ can be obtained if we use the observed response
and weight (nuisance parameters) their contribution to the likelihood function by the inverse
of the probability of observing the response (Lawless et al. 1999, p. 421). This approach will
be denoted as the weighted pseudo maximum likelihood method (WPL) which applies the
idea of the Horvitz-Thompson estimation procedure for unequal probability sampling to this
problem (Thompson (2002), p.53). Therefore, an alternative to deal with the complicated
observed data likelihood (4) would be the following weighted pseudo loglikelihood,
l(γ,ωi) = ωilogf(y
o
i |Xi, Zi,γ) (3.5)
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where ωi = pi
−1
i = (
∑H
h=1 pihδih)
−1; pih is the probability of observing the biomarker from the
ith subject belongs in dropout category h, and δih = 1 if the ith subject belongs to category
h, 0 otherwise. We assume that the estimate of pih will be obtained by a method that
produces a consistent estimate and, not necessarily by the method of maximum likelihood.
Inference for pseudo-likelihood estimates is based on the asymptotic theory and accounts for
the extra variability introduced by the use of nuisance parameters estimates. Now the score
function of the parameter of interest, γ, is
S(γ,ω) =
N∑
i=1
Riωi
∂
∂γ
logf(yoi |Xi, Zi,γ). (3.6)
The solution of S(γ, ωˆi)=0 will provide a unique Weighted Pseudo Maximum Likelihood
Estimates(WPL) of γ. The asymptotic covariance matrix of WPL γˆ has the following form
(Lawless et al. 1999, p. 426),
V ar(γˆ) = ı−111 (11 − ı12ı−122 ıT12)ı−T11 (3.7)
where
ı11(γ, ω) = E
[
N∑
i=1
−ωˆi ∂
2
∂γ∂γ′
logf(yoi |Xi, Zi; γ)|γ=γˆ
]
(3.8)
ı12(γ, ω) = E
[
N∑
i=1
{
S∗(ωi)
∂
∂γ
logf(yoi |Xi, Zi; γ)
}
|γ=γˆ,ωi=ωˆi
]
(3.9)
ı22(ω) = E
[
N∑
i=1
I∗(ωi)|ωi=ωˆi
]
(3.10)
11 = Var(S) =
N∑
i=1
SiS
T
i (3.11)
=
N∑
i=1
Ri{(
H∑
h=1
pihδih)
−1 ∂
∂γ
logf(yoi |Xi, Zi, γ)}{(
H∑
h=1
pihδih)
−1 ∂
∂γ
logf(yoi |Xi, Zi, γ)}T
and S∗(ωi) and I∗(ωi) are the score function and Fisher informatiton for the nuisancee
parameters ωi respectively. Since differential missingness or dropout is a categorical variable,
a multinomial logistic regression model and hence a likelihood function for the parameters
of the model will be developed to estimate ωi, S
∗(ωi) and I∗(ωi).
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Let us define a categorical variable D which represent three categories of patients such as
completers, dropout and death, coded as 0, 1 and 2 respectively. For simplicity in notations,
the multinomial logistic regression model will be formed by taking one covariate (observed
response, yoi ) and a constant term, denoted by the vector, x
∗ = (1, yoi )
′, of length 2. This one
covariate model can easibly be extended to the p covariate model. Now, taking completers(0)
as the reference category, dropout(1) and death(2) as comparison categories, the multinomial
logistic regression model (Agresti(2004, p.268)), can be written as
log
(
pihi
pi0i
)
= gh(x
∗
i ) = λh0 + λh1y
o
i , h = 1, 2
= (x∗i )
′θh
It follows that the conditional probability given the covariate vector in the three category
model can be obtained by the following formula:
pihi =
exp(gh(x
∗
i ))∑2
h=0 exp(gh(x
∗
i ))
(3.12)
where the vector θ0 = 0 and g0(x
∗) = 0. Each probability is a function of the vector of 4
parameters θ = (θ1
′, θ2
′). According to the outline in Hosmer and Lemeshow (2000, p. 262),
for the development of the likelihood function of the parameter vector θ, we define three(3)
dummy variables that coded as 0 or 1 to indicate the group membership of an observation.
These variables are coded as follows: if D=0 then D0 = 1, D1 = 0 and D2 = 0; if D=1 then
D0 = 0, D1 = 1 and D2 = 0; if D=2 then D0 = 0, D1 = 0 and D2 = 1. Note,
∑2
h=0Dh = 1
and these dummy variables are introduced for the construction of the likelihood function
and are not used in the actual multinomail logistic regression analysis. Using this notation,
the likelihood function for the parameter vector θ is
L(θ) =
N∏
i=1
[
pi0(xi
∗)d0ipi1(xi∗)d1ipi2(xi∗)d2i
]
(3.13)
Putting d0i = 1 − d1i − d2i for each i and taking the logarithm, the log-likelihood function
can be expressed as
logL(θ) = l(θ) =
N∑
i=1
[d1ig1(xi
∗) + d2ig2(xi∗)− log {1 + exp(g1(xi∗)) + exp(g2(xi∗))}]
(3.14)
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Taking the derivative of the log-likelihood function with respect to each of the unknown
parameters of θ, the general form of the score function is
S(θ) =
∂
∂λhk
l(θ) =
N∑
i=1
xki(dhi − pihi) (3.15)
for h=1,2; k=0,1 (subscripts for covariates) with x0i = 1 and x1i = y
o
i for each subject.
Equating the score to zero an iterative solution of θ can be obtained from these equations.
The information matrix for θˆ can be computed by taking second partial derivatives of the
above log-likelihood function:
∂2
∂λhk∂λhk′
l(θ) = −
N∑
i=1
xk′ipihi(1− pihi) (3.16)
and
∂2
∂λhk∂λh′k′
l(θ) =
N∑
i=1
xk′ixki′pihipih′i (3.17)
for h 6= h′=1,2 and k 6= k′=0,1. By negating these two sets of equations and evaluating
at θˆ a 4 × 4 observed information matrix I(θˆ) can be obtained. The ultimate purpose of
the above derivations is to derive the score function and Fisher information matrix of the
function of parameter vector θ. The score function and Fisher information of ωi which is a
function of the parameter vector θ can be derive in the following way:
S∗(ωi) =
∂
∂ωi
logL(θ) =
∂θ
∂ωi
∂
∂θ
logL(θ) =
[(
∂ωi
∂θ
)−1]
S(θ) (3.18)
and
I∗(ωi) = varS∗(ωi) =
[(
∂ωi
∂θ
)−1]′
I(θ)
[(
∂ωi
∂θ
)−1]
(3.19)
where
∂ωi
∂θ
=
∂
∂λhk
[∑2
h=0 exp(gh(x
∗
i ))
exp(gh(x∗i ))
]
= xki(1− ωhi)
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Now we will derive the score and Fisher information of the parameter vector γ to compute
ı11 and ı12 respectively. A popular model for fitting inherently unbalanced longitudinal
continuous biomarker data is the linear mixed model(LMM). A LMM for the ith subject can
be written in the following form(Laird and Ware 1982):
Yi = Xiβ + Zibi + ei (3.20)
and the vector Yi is distributed as multivariate normal with the following specification:
Yi|bi ∼ N(Xiβ + Zibi,Σi) (3.21)
bi ∼ N(0,D) (3.22)
where Xi is the ni × p design matrix for the fixed effects, β; Zi is the ni × q design matrix
for the random effects, bi; D = Cov(bi) and Σi=Cov(ei) are the covariance matrices of the
random effects and errors respectively.
From (20) the marginal distribution of Yi is normal with mean Xiβ and covariance
matrix Vi=Σi+ ZiDZ
′
i, so the log-likelihood function of the fixed parameters β is
logL(β) = −N
2
log2pi − 1
2
log|V| − 1
2
(Yi −Xiβ)′V−1(Yi −Xiβ). (3.23)
By differentiating the log-likelihood function (23) with respect to the parameter vector of β
one and two times we can compute the score and observed Fisher information respectively:
∂logL(β)
∂β
= −X′iV−1Xiβ +X′iV−1Yi (3.24)
∂2logL(β)
∂β∂β′
= X′iV
−1Xi (3.25)
20
3.3 APPLICATION: ANALYSIS OF ANTITHROMBIN BIOMARKER
DATA FROM GENIMS STUDY
The GenIMS study was a large cohort study of patients with community acquired pneumonia
followed over time. In this study, a series of biomarkers were measured daily on a subset of
hospitalized patients for seven days. These biomarkers assessed the potential pathways of
inflammation and coagulation related to the development of sepsis. The primary objective
of the GenIMS study was to identify the potential biomarkers of sepsis. There were 2320
patients enrolled through the emergency departments in 28 hospitals in PA, CT, MI, and
TN (2001-2003). From the pool of 2320 subjects we have found 939 subjects had at least
some biomarkers measurements as well as covariates information from day 1 to day 7. The
data set for our analysis consisted of 341 (36.3%) patients with seven full days of data, 579
(61.7%) patients who were discharged before the full seven days, and 19 (2.0%) patients
who died during the first 7 days. The outcome variable for our analysis is the longitudinally
measured anti-thrombin biomarker. The median level of the anti-thrombin biomarker for
patients who dropped-out was higher followed by completers, and subjects who died (Figure
1). Higher levels of anti-thrombin indicate better health condition of the subject and hence
their discharge from the hospital which resulted in drop out from the study. Patients,
who died during the study, and obviously their biomarker measurements, are missing. This
missingness mechanism of the biomarker, due to better health condition and death, is missing
not at random (MNAR) and suggests taking this into account during the analysis.
We are applying our proposed WPL method for analyzing differential reasons for miss-
ingness in the anti-thrombin longitudinal biomarker data. We will compute the weights by
inverting the probability of observing anti-thrombin biomarker data. Details on the IPW
technique have been described in section 2. These weights will account for the differential
reasons for missingness and are treated as nuisance parameters in the estimation process.
Inferences for the parameter of interests in the presence of infinite number of nuisance pa-
rameters are made using the asymptotic PL theory. We are comparing the WPL method
with the standard and weighted linear mixed models. In fitting the standard linear mixed
model it is assumed that the missingness is missing at random. In our anti-thrombin anal-
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ysis, we are considering time, time2 and statin use as fixed effects and the intercept as a
random effect in the linear mixed model.
Table 3.1 presents the results from the analysis of differential reasons for missing lon-
gitudinal anti-thrombin biomarker data using WPL method. Weighted estimates of the
parameters are larger compared to the estimates obtained from the SMM. Also the SE of
the estimate from the weighted models are larger than the corresponding SMM estimate.
Z-values for the quadratic term Day2 and Statin use by the WPL method are substantially
different from the other three methods. According to the WPL method, the Day2 term
should be dropped from the model and statin use is marginally significant. Note that the
standard error of the estimate of WPL is the largest among the four methods followed by
WMME, WMM and SMM. Again, the WPL accounts the nuisance parameters (weights) in
the computation of the variance of the estimates.
3.4 SIMULATION STUDY FOR NON-IGNORABLE MISSING
LONGITUDINAL BIOMARKER DATA
To evaluate the performance of the proposed weighted pseudo likelihood (WPL) methods,
an extensive simulation study was conducted. Using theis approach we have compared the
following models:
i) SMM: Standard linear mixed model with the SE of the estimates computed using the
Fisher information
ii) WMM: Weighted linear mixed model with the SE of the estimates computed using the
Fisher information
iii)WMME: Weighted linear mixed model with the SE of the estimates computed using the
sandwich estimator
iv) WPL: Weighted linear mixed model with the SE of the estimates computed using asymp-
totic pseudo-likelihood (PL) theory.
For our simulation study, we have generated the anti-thrombin biomarker data from
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Table 3.1: Analysis of non-ignorable missing longitudinal anti-thrombin biomarker data using
weighted pseudo likelihood method
Variable Model Coef. Std.Err. Z-statistic p-value
Intercept
SMM 4.441 0.011 399.630 <.0001
WMM 4.473 0.012 385.920 <.0001
WMME 4.473 0.025 182.500 <.0001
WPL 4.473 0.123 36.376 <.0001
Day
SMM -0.020 0.005 -4.000 <.0001
WMM -0.034 0.005 -6.470 <.0001
WMME -0.034 0.015 -2.210 0.027
WPL -0.034 0.019 -1.830 0.034
Day2
SMM 0.005 0.001 7.580 <.0001
WMM 0.006 0.001 8.130 <.0001
WMME 0.006 0.002 2.770 0.006
WPL 0.006 0.009 0.640 0.261
Statin Use
SMM 0.039 0.018 2.210 0.027
WMM 0.043 0.018 2.420 0.016
WMME 0.043 0.016 2.630 0.009
WPL 0.043 0.032 1.360 0.087
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a multivariate normal distribution with a specified mean vector and variance-covariance
matrix. The mean vector and covariance matrix were obtained from the GenIMS data. The
mean vector of the MVN distribution was as follows:
µjh = α + β0 dayj + β1 Statin Use
where Statin Use is a binary variable indicating whether patients were using statins prior
to hospitalization; j(day) = 1,...,7 and h (dropout categories) =0, 1, or 2. The covariance
of the MVN distribution has been drawn from the GenIMS study. The true values of the
parameters were set to β0=0.1 and β1=0.56. The number of subjects (sample size, N)
considered in the simulation study are 200, 500, and 1000 with a follow-up period of seven
days. One thousand iterations were performed in each simulation study. There are three
designs or scenarios have been considered for the simulation. In the first design, D1, 30% of
the subjects have complete biomarker measurements at each of the seven days (completers)
, 60% of the subjects have dropped out from the study (dropouts) , and 10% of the subjects
died (death) in the study period. For the second design D2, there are 60% completers, 30%
dropouts and 10% deaths. Third design, D3, consists of 70% completers and 30% dropouts.
The generated anti-thrombin data were set to missing from the categories of dropouts and
deaths at a rate of 10%, 20% and 30% at each wave of measurement to create missing data
in the simulation study.
After generating the longitudinal biomarker data for seven days, we have created a drop-
out categorical variable representing the three categories of subjects in the study: completers,
dropouts, deaths. Then we fitted the following multinomial logistic regression model with a
generalized logit function to compute the probabilities of observing anti-thrombin biomarker
data:
log(
φhi
φ0i
) = gh(x
∗
i ) = λh0 + λh1 dayij + λh2 Statin Usei + λh3 Antithrombini1
where i=1,2,...,N; 1 ≤ j ≤ 7 and h=1, 2. Note, baseline anti-thrombin (antithrombini1) has
been used in this logistic regression model. Using equations (12), (18), and (19), as derived
in section 2, we have computed the weights, the score, and the Fisher information to obtain
SE of the WPL estimates. The linear mixed model (20) has been fitted by considering time
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(days) and statin use as fixed effects, and by including the intercept as a random effect in the
model. Maximum likelihood estimates of the fixed effects parameters are compared in terms
of the bias, standard error (SE), root mean square error (RMSE), and coverage probability.
Table 3.2 presents the results from the analysis of simulated non-ignorable missing longi-
tudinal anti-thrombin biomarker data with 30% completers, 60% dropouts, and 10% deaths.
Results are presented for sample sizes of 200, 500, and 1000 subjects with 10% and 30% of
the outcomes subject to missing values. Biases of the estimates from the standard linear
mixed model, and weighted linear mixed models are minimal and negligible. There is no
pattern in the bias due to the sample size and percentage of missingness. The SE of the
estimates from the WPL model is the largest among the four SEs considered for the compar-
ison. Consequently, the RMSE and the coverage probabilities of the WPL estimate are also
the largest among the four estimates. The RMSE decreases with the increase in the sample
size but there is no pattern that can be observed for the percentages of missing observations
at each wave of measurement.
By comparing the all of the simulation results presented in Tables 3.2 - 3.4, we can report
that bias depends on the number of subjects with incomplete measurements due to dropouts
and deaths. Biases of the estimates are the smallest for design D3, where only 30% of the
subjects have incomplete measurements due to the dropouts. The SE of the WPL is either
a compromise or a competitor to the SE of the estimates of WMME. Similar observations
can be found in terms of RMSE. In most cases, the RMSE increases with the increase in
the percentages of missing observations but it decreases with the increases in the number
of subjects. Also the RMSE of the WPL estimator is either a compromise or a competitor
to the RMSE of the estimates of WMME. In terms of coverage probability, the WMM has
poor performance while the WPL performs as expected.
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Table 3.2: Analysis of differential reasons for missing longitudinal Anti-thrombin biomarker data with 30% completers, 60%
dropouts, and 10% deaths(True value of the parameters: β0(time)=0.1 and β1(StatinUse)=0.56)
Sample Size, N=200 Sample Size, N=500 Sample Size, N=1000
10% missing 30% missing 10% missing 30% missing 10% missing 30% missing
Statistics Model βˆt βˆs βˆt βˆs βˆt βˆs βˆt βˆs βˆt βˆs βˆt βˆs
Bias*100
SMM -0.024 0.043 0.016 0.046 0.004 -0.006 0.002 -0.012 0.000 -0.007 0.002 0.042
WMM -0.024 0.039 -0.003 0.047 -0.021 0.032 -0.007 -0.004 -0.033 0.042 -0.002 0.036
WMME -0.024 0.039 -0.003 0.047 -0.021 0.032 -0.007 -0.004 -0.033 0.042 -0.002 0.036
WPL -0.024 0.039 -0.003 0.047 -0.021 0.032 -0.007 -0.004 -0.033 0.042 -0.002 0.036
SE*100
SMM 0.200 0.963 0.187 0.973 0.127 0.619 0.148 0.624 0.090 0.438 0.105 0.442
WMM 0.198 0.965 0.198 0.979 0.126 0.622 0.146 0.631 0.089 0.441 0.103 0.447
WMME 0.319 1.038 0.295 1.028 0.207 0.672 0.220 0.660 0.148 0.480 0.157 0.471
WPL 0.368 1.288 0.402 1.236 0.234 0.823 0.320 0.785 0.166 0.580 0.227 0.558
RMSE*100
SMM 0.202 0.964 0.188 0.974 0.127 0.619 0.148 0.624 0.090 0.439 0.105 0.444
WMM 0.200 0.966 0.198 0.980 0.128 0.623 0.146 0.631 0.095 0.443 0.104 0.449
WMME 0.320 1.039 0.295 1.029 0.208 0.673 0.220 0.660 0.151 0.482 0.157 0.472
WPL 0.369 1.289 0.402 1.236 0.235 0.824 0.320 0.785 0.169 0.582 0.227 0.560
95%CP
SMM 0.85 0.95 0.88 0.95 0.86 0.92 0.85 0.92 0.86 0.94 0.84 0.94
WMM 0.75 0.92 0.81 0.95 0.80 0.89 0.78 0.91 0.76 0.95 0.82 0.95
WMME 0.94 0.95 0.96 0.96 0.95 0.92 0.95 0.93 0.96 0.97 0.97 0.96
WPL 0.96 0.99 1.00 0.99 0.96 0.97 1.00 0.97 0.97 0.99 1.00 0.98
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Table 3.3: Analysis of differential reasons for missing longitudinal Anti-thrombin biomarker data with 60% completers, 30%
dropouts, and 10% deaths (True value of the parameters: β0(time)=0.1 and β1(StatinUse)=0.56)
Sample Size, N=200 Sample Size, N=500 Sample Size, N=1000
10% missing 30% missing 10% missing 30% missing 10% missing 30% missing
Statistics Model βˆt βˆs βˆt βˆs βˆt βˆs βˆt βˆs βˆt βˆs βˆt βˆs
Bias*100
SMM 0.015 -0.078 0.016 -0.072 0.002 -0.074 -0.002 -0.031 -0.008 -0.018 -0.006 -0.009
WMM -0.013 -0.029 -0.003 -0.043 -0.013 -0.053 -0.009 -0.030 -0.043 0.043 -0.011 -0.005
WMME -0.013 -0.029 -0.003 -0.043 -0.013 -0.053 -0.009 -0.030 -0.043 0.043 -0.011 -0.005
WPL -0.013 -0.029 -0.003 -0.043 -0.013 -0.053 -0.009 -0.030 -0.043 0.043 -0.011 -0.005
SE*100
SMM 0.177 0.970 0.187 0.976 0.112 0.614 0.119 0.617 0.079 0.435 0.084 0.436
WMM 0.185 0.978 0.198 0.983 0.117 0.619 0.125 0.622 0.083 0.438 0.089 0.439
WMME 0.308 1.066 0.295 1.030 0.196 0.679 0.189 0.658 0.139 0.480 0.135 0.465
WPL 0.302 1.229 0.402 1.192 0.192 0.777 0.256 0.757 0.136 0.551 0.180 0.535
RMSE*100
SMM 0.177 0.973 0.188 0.979 0.112 0.618 0.119 0.618 0.079 0.435 0.084 0.436
WMM 0.186 0.978 0.198 0.984 0.118 0.621 0.126 0.622 0.093 0.440 0.089 0.439
WMME 0.308 1.066 0.295 1.031 0.197 0.681 0.190 0.659 0.146 0.482 0.135 0.465
WPL 0.302 1.229 0.402 1.193 0.192 0.778 0.256 0.758 0.143 0.552 0.181 0.535
95%CP
SMM 0.85 0.94 0.86 0.95 0.87 0.94 0.87 0.95 0.872 0.95 0.86 0.95
WMM 0.77 0.91 0.79 0.95 0.76 0.91 0.78 0.93 0.742 0.95 0.82 0.94
WMME 0.94 0.93 0.94 0.95 0.95 0.94 0.94 0.95 0.942 0.96 0.94 0.95
WPL 0.95 0.96 0.99 0.98 0.93 0.97 0.99 0.97 0.944 0.98 0.99 0.98
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Table 3.4: Analysis of differential reasons for missing longitudinal Anti-thrombin biomarker data with 70% completers and 30%
dropouts (True value of the parameters: β0(time)=0.1 and β1(StatinUse=0.56)
Sample Size, N=200 Sample Size, N=500 Sample Size, N=1000
10% missing 30% missing 10% missing 30% missing 10% missing 30% missing
Statistics Model βˆt βˆs βˆt βˆs βˆt βˆs βˆt βˆs βˆt βˆs βˆt βˆs
Bias*100
SMM -0.015 -0.007 -0.027 -0.031 0.011 -0.049 0.005 -0.023 0.011 0.005 -0.002 0.018
WMM -0.004 -0.024 -0.015 -0.045 0.014 -0.053 0.006 -0.025 0.014 0.001 0.000 0.016
WMME -0.004 -0.024 -0.015 -0.045 0.014 -0.053 0.006 -0.025 0.014 0.001 0.000 0.016
WPL -0.004 -0.024 -0.015 -0.045 0.014 -0.053 0.006 -0.025 0.014 0.001 0.000 0.016
SE*100
SMM 0.238 0.982 0.363 1.009 0.151 0.619 0.229 0.639 0.107 0.438 0.162 0.452
WMM 0.238 0.977 0.363 1.001 0.151 0.618 0.229 0.638 0.107 0.437 0.162 0.451
WMME 0.324 1.010 0.480 1.036 0.205 0.644 0.304 0.662 0.145 0.456 0.216 0.469
WPL 0.354 1.134 0.492 1.068 0.220 0.690 0.305 0.651 0.155 0.487 0.216 0.460
RMSE*100
SMM 0.239 0.982 0.364 1.010 0.151 0.621 0.229 0.639 0.108 0.438 0.162 0.452
WMM 0.238 0.977 0.363 1.002 0.152 0.620 0.229 0.638 0.108 0.437 0.162 0.451
WMME 0.324 1.011 0.481 1.037 0.206 0.647 0.304 0.662 0.146 0.456 0.216 0.469
WPL 0.354 1.135 0.493 1.069 0.220 0.692 0.305 0.652 0.156 0.487 0.216 0.460
95%CP
SMM 0.87 0.95 0.86 0.95 0.86 0.96 0.84 0.94 0.85 0.94 0.86 0.93
WMM 0.89 0.95 0.85 0.95 0.86 0.96 0.84 0.94 0.84 0.94 0.86 0.93
WMME 0.97 0.95 0.95 0.95 0.95 0.96 0.93 0.95 0.95 0.94 0.96 0.95
WPL 0.98 0.98 0.96 0.96 0.97 0.97 0.94 0.95 0.96 0.96 0.96 0.94
28
3.5 DISCUSSION ON THE FINDINGS OF NON-IGNORABLE MISSING
LONGITUDINAL BIOMARKER DATA ANALYSIS
For longitudinal biomarker data with differential reasons for dropout and death, the correct
specification of the full likelihood function and estimation of parameters requires infinite
dimensional integrations. Weighted pseudo likelihood (WPL) method has been proposed
for these types of longitudinal biomarker data. This WPL approach to the analysis of
longitudinally measured biomarker data with differential reasons for dropout and death is a
generalization of the weighted pseudo approach used by Lawless et al (1999). Weights were
computed by inverting the probability of response which was originally used in differential
sampling rate problems by Horvitz and Thompson. Recently Robins et al used IPW methods
in the semi-parametric regression models. Our proposed methods can be implemented using
existing statistical software. We have described and compared four models: SMM, WMM,
WMME and WPL for analyzing longitudinal biomarker data with differential reasons for
missing. Results of the WPL approach have been compared with the results of SMM, WMM
and WMME via a real data analysis and a simulation study. The WPL approach, unlike the
other weighted methods, accounts the fact that weights has been used as nuisance parameters
(weights) in the estimation.
The simulation study suggests that the WPL approach performs reasonably well com-
pared to the other standard and weighted approaches. It suffers from the fact that the
estimation of the weights is taken into account when adjusting for the missingness, resulting
in larger standard errors. The results obtained by WPL method are competitive with the
results of WMME. For all methods the bias, SE and RMSE increase with the increase in
missing observations. In terms of coverage probability the WMM is the worst performer and
WPL is a competitor to the WMME.
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4.0 ANALYSIS OF LEFT-CENSORED AND NON-IGNORABLE MISSING
LONGITUDINAL BIOMARKER DATA USING WEIGHTED PSEUDO
LIKELIHOOD THEORY
4.1 INTRODUCTION
Missing data is a persistent problem in longitudinal studies, presenting challenges at the
analysis stage and resulting in a need for methodology to address these issues. The data
may be missing due to subject drop out or death, failure to collect a subset of the data at
follow up for administrative reasons, or missing due to censoring or truncation. This loss
of data can result in biased estimates and a loss in precision. In addition, the relationship
between the outcome and predictors may vary depending on the reason for missingness and
failure to account for this in an analysis can affect the results.
The modeling of missing data has been an ongoing issue in the Genetic and Inflamma-
tory Markers of Sepsis Study (GenIMS). The GenIMS study is a longitudinal cohort study
of subjects with community acquired pneumonia that were recruited from 2001-2003 in 28
hospitals located in Pennsylvania, Connecticut, Michigan and Tennesse. One major goal of
this study was to understand the role of inflammatory markers in the progression of pneu-
monia to sepsis (Kellum, et al, 2007). The biomarkers were collected daily throughout the
first seven days of hospitalization and may be missing due to death in the hospital during
the first seven days, discharge from the hospital before day 7 or for administrative reasons.
In these settings it is likely that the pattern of any given biomarker will differ depending
on the reason for the missing data. One of the markers of greatest interest in GenIMS was
the pro-inflammatory marker IL-6; however, the measurement of IL-6 was limited due to the
sensitivity of the assay resulting in left censoring of the measure at the lower limit of detec-
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tion. Figure 4.1 presents plots of IL-6 over the seven days of measurement for three groups
of subjects; those with complete observations over days 1 - 7, those who have incomplete
observations due to hospital discharge and those who have incomplete observations due to
death during the first seven days of hospitalization. This plot points to the differences in
these groups and the need to account for this in the analysis as illustrated by the fact that
subjects who died had the highest IL-6 levels during the study.
Many methods exist for the handling of missing data in longitudinal studies when the
data are missing at random (MAR) and missing not at random (MNAR) including those
based on imputation (Rubin, 1976; Rubin, 1996, Schafer, 1997) and those based on weighting
(Robins, Rotnitzky and Zhao, 1995; Rotnitzky and Robins, 1997; Lipsitz, Ibrahim and Zhao,
1999; Lawless, Kalbfleisch and Wild, 1999; Dufouil, Brayne and Clayton, 2004; Fitzmaurice,
et al., 2005; Ibrahim et al., 2005). Using the method of weighting, greater weight is placed
on those observations that are less likely to be observed. The attraction of both imputation
and weighting is that standard methods can be used for analysis. There are also likelihood-
based methods, including selection, pattern mixture, and shared parameter models, (Little
and Rubin, 2002; Hogan et al., 2004) for analyzing MNAR or non-ignorable missing longi-
tudinal data. However, these likelihood based methods do not allow for differential reasons
for missingness and censored observations to be included in the analysis. In addition, the
estimation of the weights has not been studied in these likelihood based methods.
The inverse probability weighting (IPW) method has been used for the differential sam-
pling rate problem to account for the fact that the data are not obtained from a random
sample(Horvitz and Thompson, 1952). The idea of the IPW method is that if the prob-
ability of selecting a unit is pii then the total pi
−1
i units in the population should be used
in the estimation. Recently, the IPW method has been used for handling dropouts or an
under-represented response profile in non- or semi-parametric models (Robins and Rotnitzky,
1995). “The underlying idea is to base estimation on the observed responses but weight them
to account for the probability of remaining in the study (Fitzmaurice et al, 2004)”.
Since left-censored data arise in a variety of applications, there are many methods avail-
able to account for left-censoring in the outcome, with the tobit regression model being one
of the first models developed for this problem (Tobin, 1958). Other approaches include the
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Figure 4.1: Comparison of IL-6 levels over 7 days period by the follow-up category.
32
use of variance components (Epstein et al, 2003), imputation of the quantification limit (Keet
et al, 1997), using half of the lower limit of detection (O’Brien et al, 1998) and the use of
random imputation procedures (Paxton et al, 1997). A more efficient approach to multiple
imputation has also been proposed for analyzing censored longitudinal data using a linear
mixed model (Hugues, 1999, Jacqmin-Gadda et al, 2000).
The goal of this work is to address the problem of differentially missing longitudinal data
when the outcome is subject to left-censoring. We are proposing to extend the theory of
tobit regression and the random effects tobit model (Tobin, 1958, Epstein et al, 2003) to
develop a weighted random effects tobit (WRT) model for analyzing non-ignorable missing
and left-censored longitudinal biomarker data. The performance of the WRT model will be
compared with the random effects tobit (RT) model as well as weighted linear mixed models
(Laird and Ware, 1982). In this setting, weighted linear mixed models (WMM) will be fit by
replacing the censored values with the half of the detection limit and a randomly imputed
value. In sample survey theory the weights have been assumed to be fixed and known. Here
the IPW are computed from the observed data and hence their sampling variability will be
taken into account in the inference (Little and Rubin, 2002, p. 53). We will also consider the
IPW as nuisance parameters in the WRT model and use pseudo likelihood (PL) theory to
account for the uncertainty associated with the estimation of an infinite number of nuisance
parameters (Gong and Samaniego, 1981).
In section 4.2 we will describe the random effects tobit model and weighted random effects
tobit model for analyzing non-ignorable missing and left-censored longitudinal biomarker
data. In section 4.3 we will present an analysis of the IL-6 biomarker data from the GenIMS
study. In section 4.4 we will demonstrate the performance of the proposed model using a
simulation study. In the section 4.5 we will offer a discussion on the findings.
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4.2 NOTATION AND WEIGHTED RANDOM EFFECTS TOBIT MODEL
FORMULATION
Let Yij denote the measurement of a biomarker from the ith subject on the jth day of
measurement at time tij, i = 1, 2, ..., N, j = 1, 2, ..., ni and Xij = (Xij1, Xij2, ..., Xijp)
′ denote
a p × 1 vector of covariates associated with Yij. In vector notation, Yi = (Yi1, Yi2, ..., Yini)′
is the ni-dimensional vector of biomarker measurements and Xi is the ni × p matrix of
covariates for the ith subject. Suppose the observed, censored and missing components of
Yi are denoted by Y
o
i , Y
c
i and Y
m
i respectively. Define the missingness indicator vector as
Ri = (Ri1, Ri2, ..., Rini)
′, where Rij =0 if Yij is observed, and =1 otherwise. Note, in this
paper we will assume that Yi and Yi′ , (i 6= i′), are independent and that the covariate vector
Xij is fully observed.
Suppose we observe Yij = Y
o
ij only if Y
o
ij > c (a constant) and Yij = c if Y
o
ij ≤ c. In this
scenario, we have censored observations, since we do not observe any Yij that is less than c.
For the observations where Yij = c all we know is that Y
o
ij ≤ c, i.e., Pr(Yij = c) = Pr(Y oij ≤ c).
Under the assumption that the missing data mechanism is missing at random (MAR), the
left-censored longitudinal biomarker (e.g., IL-6) data can be analyzed utilizing the following
tobit model (Tobin, 1958, Amemiya, 1974):
Yoi = Xiβ + ²i ifY
o
i > c, (4.1)
where ²i is the usual error vector and is assumed to be distributed as a multivariate normal
with mean vector zero and variance covariance matrix Σ. To estimate the parameters in
model (1) we can use the maximum likelihood procedure. For the two sets of observations:
(i) Yij = Y
o
ij with Y
o
ij > c we can write the density function as φ[(Yi −Xiβ)/Σ] where φ(.)
is the pdf of the standard multivariate normal distribution, and (ii) Yij = c with Y
o
ij ≤ c
having the following probability
Pr[Yi = c] = Pr[Y
o
i ≤ c] = Pr[Xiβ + ²i ≤ c] = Pr[²i ≤ c−Xiβ] = Φ(co), (4.2)
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where Φ(.) is the cumulative density of the multivariate normal distribution and co = (c −
Xiβ)/Σ. From these probability specifications, the likelihood function for the parameters
associated with model (1) is given by:
L(β,Σ) =
∏
Yi>c
(2pi)−
N1
2 |Σ|− 12 exp(Yi −Xiβ)′Σ−1(Yi −Xiβ)
∏
Yi≤co
Φ((c−Xiβ)/Σ). (4.3)
Without loss of generality we can assume that the first N1 subjects have Yij = Y
0
ij and that
the remaining N0 = N −N1 have Yij = c. So the log-likelihood function can be written as
lnL = −N1
2
ln(|2piΣ|)− 1
2
N1∑
i=1
(Yi−Xiβ)′Σ−1(Yi−Xiβ)+
N∑
i=N1+1
ln[Φ((c−Xiβ)/Σ)]. (4.4)
Epstein et al. (2003) have developed a tobit variance components method in the linear mixed
model (LMM) frame work, a popular model for fitting inherently unbalanced longitudinal
continuous biomarker data. A LMM for the ith subject can be written in the following form
(Laird and Ware 1982):
Yi = Xiβ + Zibi + ei, (4.5)
where the vector Yi is distributed as multivariate normal with the following specification:
Yi|bi ∼ N(Xiβ + Zibi,Σi) (4.6)
bi ∼ N(0,D), (4.7)
where Xi is the ni × p design matrix for the fixed effects, β; Zi is the ni × q design matrix
for the random effects, bi; and D = Cov(bi) and Σi=Cov(ei) are the covariance matrices of
the random effects and errors respectively.
If there is no left-censoring in the measurements, then from (5), the marginal distribution
of Yi is normal with mean Xiβ and covariance matrix Vi=Σi+ ZiDZ
′
i. So inferences for
the fixed parameters β can be based on the following log-likelihood function:
logL(β) = −N
2
log2pi − 1
2
log|V| − 1
2
(Yi −Xiβ)′V−1(Yi −Xiβ). (4.8)
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If there is left-censoring in the biomarker measurements, the likelihood function for the
random effects tobit (RT) model (Epstein et al, 2003) can be written as
L(β,ηi) =
∏
Yi>c
f(yoi |Xi, Zi,β,ηi)
∏
Yi≤c
Pr(yci < c|Xi, Zi,β,ηi), (4.9)
where ηi denotes the i
th component of Vi. Now, the conditional distribution of Y
c
i |Yoi is
multivariate normal (Johnson and Wichern, 2001):
Yci |Yoi ∼ N(µc|oi ,Vc|oi ), (4.10)
where the mean vector and covariance matrix can be written as
µ
c|o
i = X
c
iβ + η
co
i η
oo
i
−1(yoi − µoi )
V
c|o
i = η
c
i − ηcoi ηooi −1ηoci .
Using the above quantities, the likelihood function (9) can be re-written as
L(β,ηi) =
∏
Yi>c
1
2pi|ηoo|1/2
e−
1
2
(yoi−Xoiβ)Tηooi −1(yoi−Xoiβ) (4.11)
×
∏
Yi≤c
∫ ci1
−∞
∫ ci2
−∞
· · ·
∫ cini
−∞
1
2pi|ηc|o|1/2
e−
1
2
(u−µc|oi )Tηc|oi
−1
(u−µc|oi )du.
So the log likelihood function is
l(β,ηi) =
∑
Yi>c
[−log(2pi)− 1
2
log|ηooi | −
1
2
(yoi −Xoiβ)Tηooi −1(yoi −Xoiβ)] (4.12)
+ log
∏
Yi≤c
∫ ci1
−∞
∫ ci2
−∞
· · ·
∫ cini
−∞
1
2pi|ηc|o|1/2
e−
1
2
(u−µc|oi )Tηc|oi
−1
(u−µc|oi )du.
When applying the pseudo maximum likelihood method, the likelihood function is maximized
for the parameters of interest and all other parameters are treated as nuisance parameters
(Gong and Samaniego, 1981). These nuisance parameters are replaced by their consistent
estimates in the likelihood function. Treating η as a nuisance parameter vector, the pseudo
log-likelihood and the corresponding score functions for the parameter vector β are as follows:
l(β, ηˆ) = l(β,η)|η=ηˆ (4.13)
S(β, ηˆ) =
∂
∂β
l(β, ηˆ). (4.14)
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Equations (13) and (14) define the log-likelihood function and the score function correspond-
ing to the RT model, respectively. If the missing data are ignorable, then the inferences can
be based on the RT model’s pseudo log-likelihood function (13) and its score equation (14).
For the left-censored IL-6 longitudinal biomarker data subject to non-ignorable missingness,
the likelihood function is complex (Little and Rubin, 2002). To simply this likelihood, the
pseudo likelihood method is implemented with weighting to account for missing data (Law-
less et al., 1999). These weights are incorporated by multiplying the pseudo log-likelihood
function (eq. 13) and the score function (eq. 14) of the RT model by weights. Now, the
weighted pseudo log-likelihood function and weighted score function of the RT model can be
defined as,
l(β, ηˆ, ωˆ) =
N∑
i=1
Riωˆil(β, ηˆ) (4.15)
S(β, ηˆ, ωˆ) =
N∑
i=1
Riωˆi
∂
∂β
l(β, ηˆ). (4.16)
where ωi = pi
−1
i = (
∑H
h=1 pihδih)
−1; pih is the probability of observing the biomarker from
the ith subject in dropout category h with δih = 1 if the ith subject belongs to category
h and 0 otherwise. We assume that the estimate of pih will be obtained by a plausible
estimation procedure and need not be obtained by the method of maximum likelihood. The
probability of observing a biomarker is modeled with a generalized logit model (Hosmer and
Lemeshow, 2000). The generalized logistic regression model will be fitted with covariate
vector, xi, observed response vector prior to time tj, y
o
ij=(Y
o
i1, ...,Y
o
i,j−1), and unobserved
response, ymij as described by Hogan and Laird (1997) in p. 263. Now, taking completers(0)
as the reference category, and dropout(1) and death(2) as comparison categories, the logistic
regression model can be written as
log
(
pihi
pi0i
)
= gh(x
∗
i ) = λh0 + λ
′
h1xi + λ
′
h2y
o
ij + λh3y
m
ij h = 1, 2. (4.17)
It follows that the conditional probability given the covariate vector x∗i in this three category
model can be obtained by the following formula:
pihi =
exp(gh(x
∗
i ))∑2
h=0 exp(gh(x
∗
i ))
. (4.18)
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The inference for the pseudo-likelihood estimates obtained from equation (16) is based on
asymptotic theory. The PL asymptotic SE of the estimates accounts for the extra variability
due to the use of the estimated weights, in the estimation process (Gong and Samaniego,
1981). The asymptotic covariance matrix for the parameter of interest will be obtained using
the following formula (Lawless et al. 1999, p. 427):
V ar(βˆ) ∼= A11 + A−111 V˜ A−T11 , (4.19)
where
A˜11 = −
N∑
i=1
Riωˆi
∂2
∂β∂β′
l(β, ηˆ)|β=βˆ. (4.20)
Letting, ξ˜i =
∂
∂β
l(β, ηˆ) and ¯˜ξ(h) = 1
nh
∑
i∈Dh ξ˜i, V˜ can be defined as
V˜ =
N∑
i=1
(ω2i − ωi)
∑
i∈Dh
(ξ˜i − ¯˜ξ(h))(ξ˜i − ¯˜ξ(h))T . (4.21)
Equations (15) and (16) are the log-likelihood function and score equation of the proposed
weighted random effects tobit (WRT) model, respectively. The SE of the WRT model’s
parameter estimate will be computed using formulas (19) - (21).
For comparison, we will fit a weighted linear mixed model (WMM) to the non-ignorable
missing and left-censored longitudinal data. In the WMM, the weights will be used as a
remedy for the non-ignorable missingness, and the censored values will be replaced by half
of the detection limit or a randomly imputed value. The score equation for the parameters
of interest from the WMM will be as follows,
∂logL(β)
∂β
= −X′iV−1ω Xiβ +X′iV−1ω Yi, (4.22)
where Cov(Y) = Vω = ZGZ
′ + LRL with L = diag(ω−
1
2 ). The parameters of the WMM
will be estimated by the score equation (22) and the SEs of the estimated parameters will
be computed by the variance formula in (19)-(21).
We will compare the performance of the proposed WRT model with a number of different
models. Each of these models is denoted with a subscript on both the left and right side.
The subscripts on the left side are a and r denoting the asymptotic SE from the PL theory
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and the robust SE, respectively. The subscripts on the right side are 1 , m, 7 , h, and r
denoting the use of a single weights across the wave of measurements, mis-specified weights,
seven(multiple) weights, half of the detection limit, and a randomly imputed value in the
model respectively. The models are,
(i) rRT: denotes a random effects tobit model with the SEs of the estimates computed using
the sandwich estimator.
(ii) rWRT1: denotes a weighted random effects tobit model with the SEs of the estimates
computed using the sandwich estimator.
(iii) aWRT1: denotes a weighted random effects tobit model with the SEs of the estimates
computed using the asymptotic PL theory.
(iv) aWRTm: denotes a weighted random effects tobit model with the SEs of the estimates
computed using the asymptotic PL theory. In this model, a small perturbation has been
applied to the observed probabilities (0.10 added to the observed probabilities) and hence
the weights are mis-specified.
(v) aWRT7: denotes a weighted random effects tobit model with the SEs of the estimates
computed using asymptotic PL theory. In this model, multiple (seven) weights are computed
for the multiple waves (seven days) of the IL-6 measurements.
(vi) aWMMh: denotes a weighted linear mixed model with the SEs of the estimates com-
puted using the asymptotic PL theory. In this model censored values are replaced by half of
the detection limit.
(vii) aWMMr: denotes a weighted linear mixed model with the SEs of the estimates computed
using the asymptotic PL theory. In this model censored values are replaced by randomly
imputed values.
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4.3 APPLICATION: ANALYSIS OF LEFT-CENSORED AND
NON-IGNORABLE MISSING LONGITUDINAL IL-6 BIOMARKER
DATA
The GenIMS study was a large cohort study that was designed to gain an understanding
into the role of both genetic and inflammatory biomarkers in the development of sepsis. The
study focused on recruiting patients with community acquired pneumonia (CAP) to insure
a relatively homogenous group of subjects, since sepsis can result from multiple illnesses.
A total of 2320 patients were enrolled into the study through the emergency departments
in 28 hospitals in Pennsylvania, Connecticut, Michigan, and Tennessee (2001-2003). The
focus of this analysis is on the biomarkers that were measured as part of the study. One
marker of inflammation that was obtained was interleukin-6 (IL-6), which is thought to be
a pro-inflammatory maker. The IL-6 measurements were left-censored due to the limit of
quantification and were measured daily during the first seven days of the hospitalization.
Thus the IL-6 data could be missing due to death, discharge from the hospital before day
7 or for administrative reasons. Figure 4.1 presents the plot of IL-6 over time and indicates
that the level of this biomarker depends on the reasons of missingness. This leads to non-
ignorable missingness and points to the need to take this into account in the analysis. In
this analysis, we have 330 subjects with complete IL-6 measurements, 699 subjects with
incomplete IL-6 measurements due to hospital discharge and 19 subjects with incomplete
data due to death during the first 7 days of hospitalization. We are analyzing the IL-6 data
with non-ignorable missingness using the proposed WRT method that has been described
in Section 2. In this weighted analysis the computed weights are obtained for the observed
response to account for the non-ignorable missingness. The probability of an IL-6 value being
missing is computed from a multinomial logistic regression model with dropout category as
the outcome and the following covariates: logarithm of IL-6, steroid use, pneumonia severity
index (PSI), acute physiology and chronic health evaluation (APACHE). The weights are
then computed by inverting the probabilities estimated from this model. For this example,
we fitted all of the models that have been described in section 2. The SE of the estimates has
been computed using either the sandwich estimator or the asymptotic estimator obtained
from the PL theory.
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Table 4.1: Analysis of left-censored and non-ignorable missing longitudinal IL-6 biomarker
data obtained from the GenIMS study
Covariate Model Estimate S.E. z-value p-value
Day
rRT -0.4134 0.0186 -22.24 <.0001
rWRT1 -0.3580 0.0216 -16.60 <.0001
aWRT1 -0.3580 0.0171 -20.89 <.0001
aWRTm -0.4102 0.0480 -8.55 <.0001
aWRT7 -0.4063 0.2221 -1.83 0.0673
aWMMh -0.3316 0.0134 -24.71 <.0001
aWMMr -0.3434 0.0143 -24.02 <.0001
Race
rRT 0.1167 0.1123 1.04 0.2988
rWRT1 0.1426 0.1171 1.22 0.2237
aWRT1 0.1426 0.1126 1.27 0.2041
aWRTm 0.1613 0.1431 1.13 0.2585
aWRT7 0.0823 0.1146 0.72 0.4715
aWMMh 0.1163 0.0898 1.30 0.1936
aWMMr 0.1194 0.0927 1.29 0.1971
APACHE
rRT 0.0424 0.0040 10.57 <.0001
rWRT1 0.0349 0.0044 7.92 <.0001
aWRT1 0.0349 0.0049 7.06 <.0001
aWRTm 0.0390 0.0067 5.81 <.0001
aWRT7 0.0413 0.0140 2.94 0.0029
aWMMh 0.0350 0.0038 9.13 <.0001
aWMMr 0.0354 0.0039 9.02 <.0001
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Table 4.1 presents the results obtained from the weighted random effects tobit (WRT)
analysis of IL-6 biomarker data. The parameter estimates obtained from the WRT models
are different from the estimates obtained from the RT model. The parameter estimates of
intercept, day and race obtained from the weighted random effects tobit models (rWRT1 and
aWRT1) are larger than the estimates obtained from the random effects tobit model. The
corresponding SE of the WRT model’s parameter estimates is also larger when compared to
the SE of the rRT estimates. For most of the covariates in the weighted linear mixed models
(aWMMh or aWMMr) which are fitted by replacing the censored values with half of the detec-
tion limit or a randomly imputed value, parameter estimates and SEs are relatively smaller.
Small perturbations of the computed probabilities, resulting in mis-specified weights, have
little effect on the parameter estimates and SEs. Generally, the aWRT7 model estimates are
smaller and it’s SEs are larger, hence the corresponding z-values of this model are smaller
resulting in some covariates being insignificant when compared to the other methods.
4.4 SIMULATION STUDY FOR LEFT-CENSORED AND
NON-IGNORABLE MISSING LONGITUDINAL BIOMARKER DATA
To compare the performance of the proposed weighted random effects tobit (WRT) model
with the random effects tobit (RT) model, we conducted a simulation study that was designed
to address the following issues: the handling of the missing data through the estimation of
the weights used in the model, the definition of the censored outcome, the estimation of
the variance of the estimators, and the sensitivity of the model to mis-specification of the
weights. We used several different approaches to compare methods for the estimation of
the weights and to examine the sensitivity of the estimates to potential mis-specification.
We compared the rWRT1, aWRT1, aWRTm, and aWRT7 models, with the left subscripts r
and a indicating standard errors based on the sandwich estimator and asymptotic pseudo
likelihood theory respectively. The right subscripts are 1 indicating that only one weight
is used across the wave of measurements (constant weights), m indicating that the weights
are misspecified and, 7 indicating that the weights are estimated for each of the 7 time
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points. The impact of the estimation of the variance was examined via the models rWRT1
and aWRT1, which are both weighted random tobit models with r denoting the sandwich
estimator and a denoting the asymptotic variance based on the PL theory. Finally, the
impact of ignoring the left censoring of the outcome was examined by replacing censored
values either by half of the lower limit of detection or by a randomly imputed value with the
models aWMMh and aWMMr, respectively.
We generated outcome data from a multivariate normal (MVN) distribution with a spec-
ified mean vector and variance-covariance matrix. The mean vector and covariance matrix
were obtained from the GenIMS data and all simulations are based on this underlying co-
variance structure. Based on these assumptions, the mean vector has the following form,
µjh = α + β0dayj + β1APACHEh,
where APACHE denotes a severity of illness measure that was used in the GenIMS study, j
(day) = 1,..., 7 and h(dropout categories) = 0, 1, or 2. The true values of the parameters
were set to β0=-0.1 and β1=0.07. The outcome variable was then censored based on a rate of
10%, 25% and 40% for the simulation studies. We created the missing patterns for the data
and estimated the weights based on the multinomial logistic regression model as described
in section 2 and equation (17):
log
(
pihi
pi0i
)
= gh(x
∗
i ) = λh0 + λh1dayj + λh2APACHEi + λh3(1)IL–6
o
(1)+
· · ·+ λh3,(j−1)IL–6o(j−1) + λhjIL–6mj , h = 1, 2; j > 1.
All simulations were run with three different sample sizes of 1000, 500 and 200 subjects and
a follow up period of 7 days. The results presented are based on 500 samples and three
different designs. The first design, D1, is constructed so that 60% of the subjects have
complete observations, that is, data are present for all 7 days, and the remaining 40% of the
observations are subjects to missing due to drop out. For the second design, D2, 60% of
the subjects have complete data, 30% of the subjects are missing due to drop out and the
remaining 10% have missing data due to death. Design 3, D3, consists of 30% of subjects
with complete data, 60% of the subjects missing due to drop out and the remaining 10%
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missing due to death. The missingness across waves of time points was generated in the
following manner, 5% of subjects were removed starting from the 2nd wave at all waves.
Once a subject’s data is set to missing all data at the remaining time points is also missing.
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Table 4.2: Analysis of simulated left-censored and non-ignorable missing longitudinal IL-6 biomarker data with 60% completers
and 40% dropouts(True value of the parameters: β0=-0.1 and β1=0.07)
Sample Size, N=200 Sample Size, N=1000
Censored Model βˆ0 βˆ1 RMSE(βˆ0) RMSE(βˆ1) βˆ0 βˆ1 RMSE(βˆ0) RMSE(βˆ1)
10%
rRT -0.0183 0.0085 0.0818 0.1141 -0.0916 0.0683 0.0119 0.1856
rWRT1 -0.0183 0.0082 0.0818 0.1137 -0.0912 0.0653 0.0127 0.1826
aWRT1 -0.0183 0.0082 0.1030 0.8099 -0.0912 0.0653 0.0122 0.1934
aWRTm -0.0157 0.0108 0.1166 0.7814 -0.0912 0.0654 0.0122 0.1932
aWRT7 -0.0885 0.0637 0.0327 0.4038 -0.0894 0.0661 0.0135 0.1935
aWMMh -0.0179 0.0084 0.0996 0.7884 -0.0899 0.0664 0.0127 0.1932
aWMMr -0.0180 0.0083 0.1081 0.8376 -0.0898 0.0668 0.0138 0.1961
40%
rRT -0.0133 0.0083 0.0870 0.1145 -0.0678 0.0548 0.0351 0.1753
rWRT1 -0.0122 0.0074 0.0880 0.1132 -0.0622 0.0496 0.0403 0.1694
aWRT1 -0.0122 0.0074 0.1288 0.7817 -0.0622 0.0496 0.0401 0.1794
aWRTm -0.0123 0.0074 0.1287 0.7780 -0.0623 0.0496 0.0400 0.1792
aWRT7 -0.0589 0.0487 0.0692 0.4069 -0.0612 0.0495 0.0412 0.1792
aWMMh -0.0116 0.0067 0.1039 0.5406 -0.0596 0.0460 0.0414 0.1636
aWMMr -0.0117 0.0070 0.1130 0.6273 -0.0594 0.0467 0.0420 0.1685
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Table 4.2 presents the results obtained from design D1 where 60% of the subjects have
complete observations. Results are presented for sample sizes of 200 and 1000 subjects with
10% and 40% of the outcomes subject to censoring. Note that the bias of the estimates
is heavily dependent on the sample size with the estimates for a sample size of 200 being
severely biased while the results for a sample size of 1000 indicate that the estimates are
much closer to the true values. The bias is also substantially larger when comparing the
scenarios with 10% censoring to those with 40% censoring. In all cases the estimates for
aWRT7 are the least biased and for some of the settings these are the only estimates that
are close to the true values. While the results for 25% censoring and a sample size of 500
are not presented, the overall pattern was the same. For a sample size of 200 the results for
the RMSE varied widely across the methods. For estimation of the β0 term, aWRT7 had the
smallest RMSE followed by rRT and rWRT1 while the results were flipped for the β1 term.
For a sample size of 1000, the methods were comparable across the two censoring scenarios
with RMSE increasing as the percentages of censoring increased.
In Table 4.3 we have presented the simulation results for design D2, where 30% of the
subjects are missing due to drop out and 10% have missing data due to death. For N=200
and 10% censored observations, biases associated with all of the parameter estimates are very
high with the exception of aWRT7 model parameters. Again, the aWRT7 model parameter
estimates improve consistently as the sample size increases and the censoring percentage
decreases. In most cases, the RMSE for the parameter estimates associated with the model
aWRT7 are the smallest among all weighted estimates based on the asymptotic SE of the
estimates obtained from the PL theory. Simulation results obtained from design D3 (not
presented), where 60% subjects are missing due to drop out and 10% are missing due to
death, are similar to those obtained from the other two designs. Again, the biases of the
parameter estimates are minimal for a sample size of N=1000 and the biases are large for a
sample size of N=200.
When comparing the estimates across the three simulation designs (D1 with 40% dropouts;
D2 with 30% dropouts and 10% deaths; D3 with 60% dropouts and 10% deaths) we found
that the biases of the estimate of β1 generally increased as the percentages of missing obser-
vations increased, while this was not the case for the term β0. We also found that the RMSE
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for the parameter estimates obtained from the largest sample sizes considered (N=1000)
were very similar across the designs while the results obtained for the smaller sample sizes
were more variable. Specifically for sample sizes of 200 and 500, the RMSE increased as the
percentage of censoring increased. When comparing the methods, models that accounted for
the censoring through use of tobit regression performed better than models where censored
observations were replaced by a randomly imputed value or a half of the lower limit of detec-
tion. Overall, the weighted random effects tobit model with multiple weights produced the
best estimates for small and moderate sample sizes, even with large percentages of missing
and censored observations, making this the method of choice for small and moderate sample
sizes.
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Table 4.3: Analysis of simulated left-censored and non-ignorable missing longitudinal IL-6 biomarker data with 60% completers,
30% dropouts and 10% deaths (True value of the parameters: β1=-0.1 and β2=0.07))
Sample Size, N=200 Sample Size, N=1000
Censored Model βˆ0 βˆ1 RMSE(βˆ0) RMSE(βˆ1) βˆ0 βˆ1 RMSE(βˆ0) RMSE(βˆ1)
10%
rRT -0.0183 0.0182 0.0818 0.1225 -0.0912 0.0695 0.0121 0.1839
rWRT1 -0.0165 0.0173 0.0836 0.1216 -0.0826 0.0650 0.0194 0.1800
aWRT1 -0.0165 0.0173 0.0989 0.6109 -0.0826 0.0650 0.0195 0.1858
aWRTm -0.0165 0.0172 0.0985 0.6009 -0.0827 0.0651 0.0194 0.1856
aWRT7 -0.0905 0.0889 0.0262 0.3027 -0.0906 0.0716 0.0130 0.1894
aWMMh -0.0179 0.0179 0.0966 0.5728 -0.0895 0.0681 0.0135 0.1867
aWMMr -0.0179 0.0179 0.1026 0.6050 -0.0895 0.0681 0.0145 0.1883
40%
rRT -0.0141 0.0106 0.0861 0.1155 -0.0681 0.0534 0.0348 0.1710
rWRT1 -0.0132 0.0104 0.0870 0.1153 -0.0637 0.0525 0.0389 0.1701
aWRT1 -0.0132 0.0104 0.1179 0.4739 -0.0637 0.0525 0.0388 0.1717
aWRTm -0.0133 0.0104 0.1171 0.4652 -0.0639 0.0527 0.0386 0.1717
aWRT7 -0.0667 0.0613 0.0489 0.2611 -0.0655 0.0507 0.0372 0.1698
aWMMh -0.0123 0.0096 0.1016 0.3472 -0.0597 0.0463 0.0414 0.1579
aWMMr -0.0124 0.0095 0.1079 0.3852 -0.0596 0.0466 0.0419 0.1606
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4.5 DISCUSSION ON THE FINDINGS OF LEFT-CENSORED AND
NON-IGNORABLE MISSING LONGITUDINAL BIOMARKER DATA
ANALYSIS
Analyzing left-censored and non-ignorable missing longitudinal biomarker data is a challenge.
For analyzing this type of data, we have proposed a weighted random effects tobit model. We
have compared the proposed model with the random effects tobit model (RT), a standard
model for analyzing left-censored longitudinal data. Using simulated data, four (4) WRT
models have been fitted by considering various combinations of SE and weights computation.
By replacing the censored values with a half of the detection limit or randomly imputed
values, two linear mixed models have been fitted and compared with the WRT models.
The weights are obtained by the IPW methodology, that is, the probabilities of observing a
biomarker value have been computed and inverted. These weights are used with the observed
data for recovering the contribution of missing observations in the analysis. In the estimation
process, these weights have been treated as nuisance parameters. Our interest lies in the
estimation of parameters of a weighted random effects tobit model. We have adjusted the
effects of nuisance parameters in the estimation of the SEs of the parameter estimates of
interest. Through the simulation study, we have compared the proposed WRT model with
a random effects tobit model, mis-specified WRT model, and linear mixed models.
In the simulation study, we have simulated three (3) scenarios or designs with various
percentages of missing and censored observations. Irrespective of the design, for small and
moderate sample sizes, both estimates of the coefficients are biased unless they are estimated
using the multiple weights model. Using the multiple weights model produces the smallest
bias in the estimation of parameters for both small and moderate sample sizes. All estimates
are very close to each other for large sample sizes (N=1000). Biases of the estimates increase
as the percentage of missingness increases. Biases of the estimates also depend on the
percentages of censored observations. For heavily censored data, the estimates are badly
biased though estimates obtained from using the multiple weights model are relatively less
biased. Mixed models and WRT models based on single weights produce similar estimates.
The mis-specified model which has been constructed based on a small perturbation of the
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computed probabilities, gives very similar estimates to those based on single weight WRT
and mixed models. From this simulation study we have seen that the multiple weight model’s
(aWRT7) estimates are the least biased across the designs, sample sizes, and percentages of
missing and censored observations.
For analyzing non-ignorable missing and left-censored longitudinal continuous biomark-
ers, we extend the theory of random effects tobit model. We propose the use of a multiple
weights random effects tobit model for settings where data are subject to missingness for
different reasons. We have corrected the SEs using the PL theory for the use of a large num-
ber of nuisance parameters (weights) in the estimation process. The proposed model works
well even in the setting of small to moderate sample sizes. In addition, the estimates have
the smallest bias and RMSE for small percentages of missing and censored observations.
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5.0 CONCLUSIONS
There are two issues in analyzing longitudinal biomarker data that have been addressed in
this endeavor. The first issue is the analysis of longitudinal biomarker data with dropout
and death. Though there are some likelihood based methods for analyzing non-ignorable
missing biomarker data, these methods have some concern on the issue of identifiability
along with their requirement of a rigorous computational approach for implementation. To
avoid this issue and for easy implementation in the standard software, we proposed weighted
pseudo likelihood (WPL) methods for analyzing non-ignorable missing longitudinally mea-
sured biomarker data. The proposed method has been compared with a number of methods.
We have tested the method by analyzing a real data set obtained from the GenIMS study
and performed a simulation study. A standard method for analyzing longitudinal data is the
standard linear mixed (SMM) model. Though the SMM model fit gives smaller biases, SE
estimates, and RMSE estimates, it does not account the fact that the data are non-ignorable
missing. The weighted linear mixed model (WMM) has been fitted with the intention to
capture the missing data. Using this method, the SE of the estimate was not corrected due
to the uncertainty of estimating weights. For comparison, we have fitted the WMM with
the robust SE estimate. This SE estimate does not take into consideration the fact that the
nuisance parameters have been used in the estimation process either. The proposed WPL
method corrects the computed SE estimate. The three weighted methods produce same bi-
ases. The SE and RMSE of the WPL method estimate are competitive to the SE and RMSE
of the WMME method estimate. The coverage probabilities for the regression coefficients
estimates by the WMME and WPL methods vary according to the designs. No method is
consistently performing over the other method across the designs.
The second issue for analyzing longitudinal biomarker data is the left-censoring. In addi-
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tion to the non-ignorable missingness, left-censoring gives another non-trivial challenge to the
analyst. Though there are some likelihood based methods for analyzing left-censored and/or
non-ignorable missing longitudinal data, none of these methods are based on weighting tech-
niques. We proposed a weighted random effect tobit (WRT) model based on weighted pseudo
likelihood theory. This proposed model has been compared with the un-weighted random
effects tobit model. Also for the comparison, several WRT models have been fitted either
by varying the SE estimation procedure or by varying replacement methods for the censored
observations. The real (IL-6 biomarker) data analysis shows that the z-values differs among
the weighted methods. Again, only the SE estimates based on the WPL method account
for the effect of nuisance parameters in the estimation process. From the simulation study
it can be inferred that the WRT model using WPL theory and censored values replaced by
the detection limit produce smallest root mean square error (RMSE). Simulation study also
indicates that, instead of using a single weight across the panels, use of multiple weights
produce smallest RMSE. Therefore, for analyzing non-ignorable missing and left-censored
longitudinal biomarker data, a WRT model based on WPL theory with censored values
replaced by the detection limit and use of multiple weights would be recommended.
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